Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Pfeifer Thomas |
** = Publikationen gelistet in SCI/SSCI/Pubmed
2011
Originalarbeit (Zeitschrift)
** Rohde, E; Schallmoser, K; Reinisch, A; Hofmann, NA; Pfeifer, T; Fröhlich, E; Rechberger, G; Lanzer, G; Kratky, D; Strunk, D
Pro-angiogenic induction of myeloid cells for therapeutic angiogenesis can induce mitogen-activated protein kinase p38-dependent foam cell formation.
Cytotherapy. 2011; 13(4):503-512
Doi: 10.3109/14653249.2010.536214
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2010
Abstract (Zeitschrift)
** Rohde, E; Schallmoser, K; Reinisch, A; Hofmann, N; Pfeifer, T; Rechberger, G; Lanzer, G; Kratky, D; Strunk, D
BLOOD AND MARROW-DERIVED PROGENITORS ARE SUSCEPTIBLE TO MAPK P38-DEPENDENT FOAM CELL INDUCTION
HAEMATOL-HEMATOL J. 2010; 95: 1059-
[Poster]
Web of Science
** Rohde, E; Schallmoser, K; Reinisch, A; Hofmann, NA; Pfeifer, T; Rechberger, G; Lanzer, G; Linkesch, W; Kratky, D; Strunk, D
MAPK p38-dependent foam cell formation of myeloid cells after pro-angiogenic induction as a risk factor of therapeutic angiogenesis
BONE MARROW TRANSPLANT. 2010; 45: S283-S283. -36th Annual Meeting of the European Group for Blood and Marrow Transplantation; MAR 21-24, 2010; Vienna, AUSTRIA.
[Poster]
Web of Science
2009
Originalarbeit (Zeitschrift)
** Kratzer, A; Buchebner, M; Pfeifer, T; Becker, TM; Uray, G; Miyazaki, M; Miyazaki-Anzai, S; Ebner, B; Chandak, PG; Kadam, RS; Calayir, E; Rathke, N; Ahammer, H; Radovic, B; Trauner, M; Hoefler, G; Kompella, UB; Fauler, G; Levi, M; Levak-Frank, S; Kostner, GM; Kratky, D
Synthetic LXR agonist attenuates plaque formation in apoE-/- mice without inducing liver steatosis and hypertriglyceridemia.
J Lipid Res. 2009; 50(2): 312-326.
Doi: 10.1194/jlr.M800376-JLR200
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Abstract (Zeitschrift)
** Rohde, E; Pfeifer, T; Schallmoser, K; Reinisch, A; Hofmann, NA; Froehlich, E; Rechberger, G; Lanzer, G; Kratky, D; Strunk, D
Pro-atherogenic risk of cellular therapy for vascular regeneration?
BONE MARROW TRANSPLANT. 35th Annual Meeting of the European Group for Blood and Marrow Transplantation2009; 43(1):S203-S204.-35th Annual Meeting of the European Group for Blood and Marrow Transplantation; MAR 29-APR 01, 2009; Goteborg, SWEDEN.
[Poster]
Web of Science